Table 2: PTCL subtypes disease stage.

 

Stage

Total

PTCL subtype [N = 60]

stage

n

%

n

%

Cutaneous

 

 

 

9

15.0%

Mycosis fungoides

4

1

100%

1

1.7%

Transformed mycosis fungoides

4

1

100%

1

1.7%

Sézary syndrome

4

3

100%

3

5.1%

Primary cutaneous CD30 positive T-cell lymphoproliferative

missing

1

25%

4

6.8%

1

2

50%

3

1

25%

Extranodal

8

13.3%

NKTCL nasal type

1

1

20%

5

8.5%

2

3

60%

4

1

20%

Enteropathy-associated TCL

2

1

33%

3

5.1%

4

2

67%

Nodal

27

45.0%

PTCL-NOS

3

4

33%

12

20.3%

4

8

67%

Anaplastic large cell lymphoma (ALK+/-)

2

2

20%

10

16.9%

3

3

30%

4

5

50%

Angioimmunoblastic TCL

3

2

40%

5

8.5%

4

3

60%

Leukemic

 

13

21.7%

Adult T-cellleukemia/lymphoma

4

10

100%

10

16.9%

T-cell prolymphocytic leukemia

4

1

100%

1

1.7%

T-cell large granular lymphocytic leukemia

4

2

100%

2

3.4%

Lymphoblastic T-cell lymphoma

2

1

50%

2

3.4%

4

1

50%

Subtype data missing

1

1

100%

1

1.7%